189 related articles for article (PubMed ID: 5395883)
1. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
Földes J; Takó J; Bános C; Gesztesi E; Varga I
Acta Med Acad Sci Hung; 1969; 26(3):233-43. PubMed ID: 5395883
[No Abstract] [Full Text] [Related]
2. [Studies on the problem of a relationship between the occurrence of thyroid antibodies and LATS in hyperthyreosis].
Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
Med Klin; 1966 Dec; 61(52):2062-3. PubMed ID: 5999210
[No Abstract] [Full Text] [Related]
3. LATS and Graves' disease.
Soloman DH; Chopra IJ
Calif Med; 1970 Aug; 113(2):50-5. PubMed ID: 5538194
[No Abstract] [Full Text] [Related]
4. Familial incidence of long-acting thyroid stimulator (LATS) in Graves' disease.
Bonnyns M; Vanhaelst L
Horm Metab Res; 1972 Mar; 4(2):132. PubMed ID: 5067566
[No Abstract] [Full Text] [Related]
5. Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.
Knight A; Adams DD
Clin Exp Immunol; 1983 May; 52(2):317-24. PubMed ID: 6134598
[TBL] [Abstract][Full Text] [Related]
6. [Simultaneous study of LATS and antimicrosomial antibodies in untreated Basedow's disease].
Orgiazzi J; Pousset G; Durand H
Presse Med (1893); 1971 May; 79(25):1167-8. PubMed ID: 4933634
[No Abstract] [Full Text] [Related]
7. Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.
Banovac K; Zakarija M; McKenzie JM; Witte A; Sekso M
J Clin Endocrinol Metab; 1981 Sep; 53(3):651-3. PubMed ID: 6790561
[TBL] [Abstract][Full Text] [Related]
8. ["Long-acting thyroid stimulator" (LATS) and conventional thyroid antibodies. Comparative studies].
Depisch D; Höfer R; Schatz H
Wien Z Inn Med; 1968; 49(11):418-22. PubMed ID: 5737591
[No Abstract] [Full Text] [Related]
9. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
Volpé R; Desbarats-Schonbaum ML; Schonbaum E; Row VV; Ezrin C
Am J Med; 1969 Feb; 46(2):217-26. PubMed ID: 5818477
[No Abstract] [Full Text] [Related]
10. Heterogeneity of long acting thyroid stimulating (LATS)-activity, thyroglobulin antibodies and thyroid microsomal antibodies.
Adlkofer F; Schleusener H; Uher L; Ananos A
Acta Endocrinol (Copenh); 1973 Jul; 73(3):483-8. PubMed ID: 4740843
[No Abstract] [Full Text] [Related]
11. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
Mori T; Fisher J; Kriss JP
J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
[No Abstract] [Full Text] [Related]
12. Autoimmune thyroid disease: an integrated concept of Graves' and Hashimoto's diseases.
Selenkow HA; Wyman P; Allweiss P
Compr Ther; 1984 Apr; 10(4):48-56. PubMed ID: 6373115
[TBL] [Abstract][Full Text] [Related]
13. [LATS and Graves' disease].
Gordon A
Harefuah; 1971 May; 80(10):569-70. PubMed ID: 5171988
[No Abstract] [Full Text] [Related]
14. Investigation of endocrine exophthalmos.
Bowden AN; Ross FC
Proc R Soc Med; 1969 Jan; 62(1):13-5. PubMed ID: 5818230
[No Abstract] [Full Text] [Related]
15. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
Silverstein GE; Burke G
Arch Intern Med; 1970 Oct; 126(4):615-20. PubMed ID: 4097002
[No Abstract] [Full Text] [Related]
16. Relationship between the long-acting thyroid stimulator and the thyroid microsomal antibody.
Bonnyns M; Vanhaelst L
J Endocrinol; 1969 Jan; 43(1):125-6. PubMed ID: 4886576
[No Abstract] [Full Text] [Related]
17. [Clinical and hormonal development of a case of malignant exophthalmus after hypophyseal myskiotomy].
Stoica T; Arseni C; Constantinescu A; Coculescu M; Balmeş E
Endocrinologie; 1977; 15(4):283-8. PubMed ID: 579476
[TBL] [Abstract][Full Text] [Related]
18. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
[TBL] [Abstract][Full Text] [Related]
19. What is the antibody specificity of LATS?
Fagraeus A; Jonsson J; el-Kabir DJ
J Clin Endocrinol Metab; 1970 Oct; 31(4):445-7. PubMed ID: 4916544
[No Abstract] [Full Text] [Related]
20. LATS in Graves' disease.
McKenzie JM; Zakarija M
Recent Prog Horm Res; 1976; 33():29-57. PubMed ID: 198858
[No Abstract] [Full Text] [Related]
[Next] [New Search]